Aurobindo Pharma

Aurobindo Pharma Limited
TypePublic
NSE: AUROPHARMA
BSE: 524804
IndustryPharmaceuticals
Founded1986 (1986)
FoundersV. Ramprasad Reddy
K. Nityananda Reddy
HeadquartersHyderabad, Telangana, India
Products
RevenueIncrease ₹31,724 crore (US$3.3 billion) (2025)
Increase ₹6,605 crore (US$690 million) (2025)
Increase ₹3,484 crore (US$360 million) (2025)
Total assetsIncrease ₹49,748 crore (US$5.2 billion) (2025)
Total equityIncrease ₹32,646 crore (US$3.4 billion) (2025)
Number of employees
23,000 (2020)
SubsidiariesLannett Company
Websitewww.aurobindo.com
Footnotes
Financials as of 31 March 2025.

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca.